You have 9 free searches left this month | for more free features.

NPDR

Showing 76 - 90 of 90

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using

Completed
  • Type 2 Diabetes
  • Non Proliferative Diabetic Retinopathy
    • Coimbra, Portugal
      Centre for Clinical Trials- AIBILI - Association for Innovation
    Feb 10, 2015

    Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2

    Completed
    • Type-2 Diabetes
    • Diabetic Retinopathy
      • Coimbra, Portugal
        AIBILI - Clinical Trials Centre (CEC)
      Oct 7, 2015

      Diabetic Macular Edema Trial in Augusta (Ranibizumab 0.3mg/0.05cc)

      Unknown status
      • Diabetic Macular Edema
      • Ranibizumab 0.3mg/0.05cc
      • Augusta, Georgia
        Southeast Retina Center, PC
      Sep 16, 2014

      Diabetic Retinopathy, Diabetic Macular Edema Trial in Salt Lake City (Ranibizumab (Lucentis), Argon Laser)

      Completed
      • Diabetic Retinopathy
      • Diabetic Macular Edema
      • Ranibizumab (Lucentis)
      • Argon Laser
      • Salt Lake City, Utah
        Rocky Mountain Retina Consultants
      May 5, 2014

      Diabetic Retinopathy Compared to Clinical Examination

      Completed
      • Diabetic Retinopathy
      • Photography of the retina
      • Retinal photography
      • Mesa, Arizona
      • +6 more
      Apr 21, 2014

      Diabetic Macular Edema and Diabetic Retinopathy Screening With

      Unknown status
      • Mild Nonproliferative Diabetic Retinopathy
      • +4 more
        • Hilo, Hawaii
          Craig Kadooka, MD
        Feb 12, 2013

        Diabetic Retinopathy Trial (Octreotide acetate in microspheres)

        Terminated
        • Diabetic Retinopathy
        • Octreotide acetate in microspheres
        • (no location specified)
        Apr 30, 2012

        Diabetic Retinopathy Trial (Octreotide acetate in microspheres)

        Terminated
        • Diabetic Retinopathy
        • Octreotide acetate in microspheres
        • (no location specified)
        Apr 8, 2012

        Diabetic Retinopathy Trial in East Hanover (Octreotide Acetate in Microspheres, Placebo)

        Completed
        • Diabetic Retinopathy
        • Octreotide Acetate in Microspheres
        • Placebo
        • East Hanover, New Jersey
          Novartis
        Nov 16, 2011

        Diabetic Retinopathy Trial in East Hanover (Octreotide Acetate in Microspheres 20 mg, Octreotide Acetate in Microspheres,

        Completed
        • Diabetic Retinopathy
        • Octreotide Acetate in Microspheres 20 mg
        • +2 more
        • East Hanover, New Jersey
          Novartis
        Nov 16, 2011

        Diabetes Trial in Taipei (Actos (Pioglitazone), Acarbose)

        Unknown status
        • Diabetes
        • Taipei, Taiwan
          Taipei Veterans General Hospital, Taiwan
        Jan 4, 2011

        Diabetic Retinopathy Trial in Cleveland (triamcinolone acetonide (Kenalog))

        Completed
        • Diabetic Retinopathy
        • triamcinolone acetonide (Kenalog)
        • Cleveland, Ohio
          Cole Eye Institute
        Nov 9, 2010

        Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in

        Unknown status
        • Type 2 Diabetes Mellitus
        • +2 more
          • Beer-Sheva, Israel
            Soroka University Medical Center
          Apr 19, 2010

          Macular Edema Trial in Mexico (Bevacizumab, Panretinal Photocoagulation)

          Completed
          • Macular Edema
          • Mexico, DF, Mexico
            Asociación para Evitar la Ceguera en México
          Dec 3, 2008

          Proliferative Diabetic Retinopathy Trial in Shawnee Mission (Lucentis (ranibizumab))

          Unknown status
          • Proliferative Diabetic Retinopathy
          • Lucentis (ranibizumab)
          • Shawnee Mission, Kansas
            Retina Associates, PA
          Aug 14, 2007